Transgene Revenue

In the year 2024, Transgene had annual revenue of 6.35M EUR, down -19.58%. Transgene had revenue of 3.00M in the half year ending December 31, 2024, a decrease of -29.62%.

Revenue

6.35M EUR

Revenue Growth

-19.58%

P/S Ratio

13.12

Revenue / Employee

44.12K EUR

Employees

144

Market Cap

68.93M GBP

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.35M	-1.55M	-19.58%
Dec 31, 2023	7.90M	-2.44M	-23.63%
Dec 31, 2022	10.34M	-6.90M	-40.00%
Dec 31, 2021	17.24M	7.67M	80.08%
Dec 31, 2020	9.57M	-3.72M	-28.00%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	43.19B
GSK plc	31.38B
Haleon	11.23B
Smith & Nephew	4.64B
ConvaTec Group	1.83B
Hikma Pharmaceuticals	2.50B
HUTCHMED (China)	503.39M
Oxford Nanopore Technologies	183.19M

Revenue Rankings